Freeman officials discuss Merck COVID treatment pill
JOPLIN, Mo. – At the Freeman media briefing today officials discussed declining COVID cases as well, including a decline in the number of people hospitalized with COVID.
Additionally, Freeman’s Chief Clinical Officer, Jeff Thompson, discussed the new Merck pill, that’s designed to treat COVID. Merck requested emergency use authorization from the FDA on Monday and Thompson says there are still a number of unanswered questions on exactly how the pill will roll out.
Thompson says “The way it’s been studied, the dosage has not been set and that will be in the emergency use authorization, but it’s a twice a day pill for five days is what it looks like it will probably be, but that exact dosage hasn’t been laid out yet.”
Thompson adds in addition to getting the COVID vaccine, everyone needs to make sure they get their flu shot this year as well.
COPYRIGHT 2021 BY KOAM NEWS NOW. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.